133 related articles for article (PubMed ID: 28180184)
1. A gain-of-function mutation in the
Guzmán YF; Ramsey K; Stolz JR; Craig DW; Huentelman MJ; Narayanan V; Swanson GT
Neurol Genet; 2017 Feb; 3(1):e129. PubMed ID: 28180184
[TBL] [Abstract][Full Text] [Related]
2. Clustered mutations in the GRIK2 kainate receptor subunit gene underlie diverse neurodevelopmental disorders.
Stolz JR; Foote KM; Veenstra-Knol HE; Pfundt R; Ten Broeke SW; de Leeuw N; Roht L; Pajusalu S; Part R; Rebane I; Õunap K; Stark Z; Kirk EP; Lawson JA; Lunke S; Christodoulou J; Louie RJ; Rogers RC; Davis JM; Innes AM; Wei XC; Keren B; Mignot C; Lebel RR; Sperber SM; Sakonju A; Dosa N; Barge-Schaapveld DQCM; Peeters-Scholte CMPCD; Ruivenkamp CAL; van Bon BW; Kennedy J; Low KJ; Ellard S; Pang L; Junewick JJ; Mark PR; Carvill GL; Swanson GT
Am J Hum Genet; 2021 Sep; 108(9):1692-1709. PubMed ID: 34375587
[TBL] [Abstract][Full Text] [Related]
3. A Pathogenic Missense Mutation in Kainate Receptors Elevates Dendritic Excitability and Synaptic Integration through Dysregulation of SK Channels.
Nomura T; Taniguchi S; Wang YZ; Yeh NH; Wilen AP; Castillon CCM; Foote KM; Xu J; Armstrong JN; Savas JN; Swanson GT; Contractor A
J Neurosci; 2023 Nov; 43(47):7913-7928. PubMed ID: 37802657
[TBL] [Abstract][Full Text] [Related]
4. Identification of critical functional determinants of kainate receptor modulation by auxiliary protein Neto2.
Griffith TN; Swanson GT
J Physiol; 2015 Nov; 593(22):4815-33. PubMed ID: 26282342
[TBL] [Abstract][Full Text] [Related]
5. Neto2 Assembles with Kainate Receptors in DRG Neurons during Development and Modulates Neurite Outgrowth in Adult Sensory Neurons.
Vernon CG; Swanson GT
J Neurosci; 2017 Mar; 37(12):3352-3363. PubMed ID: 28235897
[TBL] [Abstract][Full Text] [Related]
6. Ionotropic and metabotropic kainate receptor signalling regulates Cl
Garand D; Mahadevan V; Woodin MA
J Physiol; 2019 Mar; 597(6):1677-1690. PubMed ID: 30570751
[TBL] [Abstract][Full Text] [Related]
7. De novo mutation screening in childhood-onset cerebellar atrophy identifies gain-of-function mutations in the CACNA1G calcium channel gene.
Chemin J; Siquier-Pernet K; Nicouleau M; Barcia G; Ahmad A; Medina-Cano D; Hanein S; Altin N; Hubert L; Bole-Feysot C; Fourage C; Nitschké P; Thevenon J; Rio M; Blanc P; Vidal C; Bahi-Buisson N; Desguerre I; Munnich A; Lyonnet S; Boddaert N; Fassi E; Shinawi M; Zimmerman H; Amiel J; Faivre L; Colleaux L; Lory P; Cantagrel V
Brain; 2018 Jul; 141(7):1998-2013. PubMed ID: 29878067
[TBL] [Abstract][Full Text] [Related]
8. Whole Exome Sequencing and Heterologous Cellular Electrophysiology Studies Elucidate a Novel Loss-of-Function Mutation in the CACNA1A-Encoded Neuronal P/Q-Type Calcium Channel in a Child With Congenital Hypotonia and Developmental Delay.
Weyhrauch DL; Ye D; Boczek NJ; Tester DJ; Gavrilova RH; Patterson MC; Wieben ED; Ackerman MJ
Pediatr Neurol; 2016 Feb; 55():46-51. PubMed ID: 26739101
[TBL] [Abstract][Full Text] [Related]
9. Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities.
Baasch AL; Hüning I; Gilissen C; Klepper J; Veltman JA; Gillessen-Kaesbach G; Hoischen A; Lohmann K
Epilepsia; 2014 Apr; 55(4):e25-9. PubMed ID: 24579881
[TBL] [Abstract][Full Text] [Related]
10. Reduced synaptic function of Kainate receptors in the insular cortex of Fmr1 Knock-out mice.
Qiu S; Wu Y; Lv X; Li X; Zhuo M; Koga K
Mol Brain; 2018 Sep; 11(1):54. PubMed ID: 30241548
[TBL] [Abstract][Full Text] [Related]
11. Exome sequencing analysis in a pair of monozygotic twins re-evaluates the genetics behind their intellectual disability and reveals a CHD2 mutation.
Pinto AM; Bianciardi L; Mencarelli MA; Imperatore V; Di Marco C; Furini S; Suppiej A; Salviati L; Tenconi R; Ariani F; Mari F; Renieri A
Brain Dev; 2016 Jun; 38(6):590-6. PubMed ID: 26754451
[TBL] [Abstract][Full Text] [Related]
12. De novo mutations in CSNK2A1 are associated with neurodevelopmental abnormalities and dysmorphic features.
Okur V; Cho MT; Henderson L; Retterer K; Schneider M; Sattler S; Niyazov D; Azage M; Smith S; Picker J; Lincoln S; Tarnopolsky M; Brady L; Bjornsson HT; Applegate C; Dameron A; Willaert R; Baskin B; Juusola J; Chung WK
Hum Genet; 2016 Jul; 135(7):699-705. PubMed ID: 27048600
[TBL] [Abstract][Full Text] [Related]
13. Novel de novo SPOCK1 mutation in a proband with developmental delay, microcephaly and agenesis of corpus callosum.
Dhamija R; Graham JM; Smaoui N; Thorland E; Kirmani S
Eur J Med Genet; 2014 Mar; 57(4):181-4. PubMed ID: 24583203
[TBL] [Abstract][Full Text] [Related]
14. Assembly and Trafficking of Homomeric and Heteromeric Kainate Receptors with Impaired Ligand Binding Sites.
Scholefield CL; Atlason PT; Jane DE; Molnár E
Neurochem Res; 2019 Mar; 44(3):585-599. PubMed ID: 30302614
[TBL] [Abstract][Full Text] [Related]
15. The glutamate receptor GluK2 contributes to the regulation of glucose homeostasis and its deterioration during aging.
Abarkan M; Gaitan J; Lebreton F; Perrier R; Jaffredo M; Mulle C; Magnan C; Raoux M; Lang J
Mol Metab; 2019 Dec; 30():152-160. PubMed ID: 31767166
[TBL] [Abstract][Full Text] [Related]
16. Determination of kainate receptor subunit ratios in mouse brain using novel chimeric protein standards.
Watanabe-Iida I; Konno K; Akashi K; Abe M; Natsume R; Watanabe M; Sakimura K
J Neurochem; 2016 Jan; 136(2):295-305. PubMed ID: 26448475
[TBL] [Abstract][Full Text] [Related]
17. First de novo KCND3 mutation causes severe Kv4.3 channel dysfunction leading to early onset cerebellar ataxia, intellectual disability, oral apraxia and epilepsy.
Smets K; Duarri A; Deconinck T; Ceulemans B; van de Warrenburg BP; Züchner S; Gonzalez MA; Schüle R; Synofzik M; Van der Aa N; De Jonghe P; Verbeek DS; Baets J
BMC Med Genet; 2015 Jul; 16():51. PubMed ID: 26189493
[TBL] [Abstract][Full Text] [Related]
18. Identification and functional characterization of de novo FOXP1 variants provides novel insights into the etiology of neurodevelopmental disorder.
Sollis E; Graham SA; Vino A; Froehlich H; Vreeburg M; Dimitropoulou D; Gilissen C; Pfundt R; Rappold GA; Brunner HG; Deriziotis P; Fisher SE
Hum Mol Genet; 2016 Feb; 25(3):546-57. PubMed ID: 26647308
[TBL] [Abstract][Full Text] [Related]
19. De Novo Mutations Affecting the Catalytic Cα Subunit of PP2A, PPP2CA, Cause Syndromic Intellectual Disability Resembling Other PP2A-Related Neurodevelopmental Disorders.
Reynhout S; Jansen S; Haesen D; van Belle S; de Munnik SA; Bongers EMHF; Schieving JH; Marcelis C; Amiel J; Rio M; Mclaughlin H; Ladda R; Sell S; Kriek M; Peeters-Scholte CMPCD; Terhal PA; van Gassen KL; Verbeek N; Henry S; Scott Schwoerer J; Malik S; Revencu N; Ferreira CR; Macnamara E; Braakman HMH; Brimble E; Ruzhnikov MRZ; Wagner M; Harrer P; Wieczorek D; Kuechler A; Tziperman B; Barel O; de Vries BBA; Gordon CT; Janssens V; Vissers LELM
Am J Hum Genet; 2019 Jan; 104(1):139-156. PubMed ID: 30595372
[TBL] [Abstract][Full Text] [Related]
20. Burden of de novo mutations and inherited rare single nucleotide variants in children with sensory processing dysfunction.
Marco EJ; Aitken AB; Nair VP; da Gente G; Gerdes MR; Bologlu L; Thomas S; Sherr EH
BMC Med Genomics; 2018 May; 11(1):50. PubMed ID: 29801487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
